secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2025-06-26T23:59:59+00:00
Accession:  0001213900-25-058380
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio to announce top line Phase 2 MINDFuL Alzheimer's data on June 30
---------------------------------------------------------------------------

- Conference call scheduled for June 30, 2025 at 8:00 AM ET to present top line Phase 2 MINDFuL results.
- MINDFuL trial is a Phase 2 study in early Alzheimer's disease.
- Press release issued June 26, 2025 announcing the upcoming data call.
- Dial-in: +1-800-267-6316 (US) or +1-203-518-9783 (international), Conference ID: INMUNE.
- Replay available through July 30, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025058380/0001213900-25-058380-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025058380/ea0247096-8k_inmune.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-058380

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer